Galectin Therapeutics Inc. (GALT)

[biotech2010]

They obviously have some of the data and this note about reporting interim results in the very near future would have to be a positive unless Traber and his BOD have completely lost their minds (which is doubtful).

Their hedge fund investors recently filed to sell their warrants, which would only come into play if the stock were over $2.50-the exercise of those warrants would give them substantial additional cash, maybe we will see a bump (at least temporary) with some positive psoriasis news (which would be a welcome change for all of us).